← Back to Patent Explorer
US4526787A Expired / Lapsed US ⏱️ 0.0 years remaining

N-heterocyclic retinoic acid analogues

Assignee: SRI International Inc
•
Filing: 1983-03-28
•
Granted: 1985-07-02
•
Expires: 2003-03-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A compound of the formula: <IMAGE> where X is <IMAGE> +TR <IMAGE> and R is hydroxy, or an alkoxy with 0 or 1 hydroxy substituent, or aroxy with 0 or 1 hydroxy substituent, or alkoxy monosubstituted phenoxy, or NR1R2 where R1 is hydrogen, or an alkyl or aryl with 0 or 1 hydroxy substituent, and R2 is an alkyl or aryl with 0 or 1 hydroxy substituent. These compounds are useful as chemopreventive agents for inhibiting tumor promotion in ephithelial cells and for treating nonmalignant skin disorders.

Inventors

  • 👤 Marcia I. Dawson
  • 👤 Rebecca L. S. Chan
  • 👤 Peter D. Hobbs

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 15:40
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/28; C07D213/30; C07D213/44; C07D213/46; C07D213/48; C07D213/60; C07D213/78; C07D213/79; C07D213/80

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 94 words
A compound of the formula: ##STR7## where X is ##STR8## and R is hydroxy, alkoxy of 1 to 10 carbon atoms with 0 or 1 hydroxy substituent, phenoxy, monohydroxyphenoxy, monoalkoxyphenoxy where the alkoxy group contains 1 to 4 carbon atoms with 0 or 1 hydroxy substituent, or --NR 1 R 2 where R 1 is hydrogen, alkyl of 1 to 8 carbon atoms with 0 or 1 hydroxy substituent, phenyl, 4-hydroxyphenyl, or 4-methoxyphenyl, and R 2 is alkyl of 1 to 8 carbon atoms with 0 or 1 hydroxy substituent, phenyl, 4-hydroxyphenyl, or 4-methoxyphenyl.
Claim 2
Dependent Claim 94 words
A compound of the formula: ##STR7## where X is ##STR8## and R is hydroxy, alkoxy of 1 to 10 carbon atoms with 0 or 1 hydroxy substituent, phenoxy, monohydroxyphenoxy, monoalkoxyphenoxy where the alkoxy group contains 1 to 4 carbon atoms with 0 or 1 hydroxy substituent, or --NR 1 R 2 where R 1 is hydrogen, alkyl of 1 to 8 carbon atoms with 0 or 1 hydroxy substituent, phenyl, 4-hydroxyphenyl, or 4-methoxyphenyl, and R 2 is alkyl of 1 to 8 carbon atoms with 0 or 1 hydroxy substituent, phenyl, 4-hydroxyphenyl, or 4-methoxyphenyl.
Claim 3
Dependent Claim 36 words
The compound of claim 1 wherein the alkoxy group represented by R contains 1 to 4 carbon atoms and the alkyl groups represented by R 1 and R 2 each contain 1 to 4 carbon atoms.
Claim 4
Dependent Claim 11 words
The compound of claim 1 wherein R is ethoxy or hydroxy.
Claim 5
Dependent Claim 6 words
A compound of the formula: ##STR9##
Claim 6
Dependent Claim 6 words
A compound of the formula: ##STR9##
Claim 7
Dependent Claim 32 words
A therapeutic composition for treating a non-malignant skin disorder susceptible to treatment by retinoic acid comprising a therapeutically effective amount of the compound of claim 1, combined with a pharmaceutically acceptable carrier.
Claim 8
Dependent Claim 32 words
A therapeutic composition for treating a non-malignant skin disorder susceptible to treatment by retinoic acid comprising a therapeutically effective amount of the compound of claim 2, combined with a pharmaceutically acceptable carrier.
Claim 9
Dependent Claim 32 words
A therapeutic composition for treating a non-malignant skin disorder susceptible to treatment by retinoic acid comprising a therapeutically effective amount of the compound of claim 3, combined with a pharmaceutically acceptable carrier.
Claim 10
Dependent Claim 32 words
A therapeutic composition for treating a non-malignant skin disorder susceptible to treatment by retinoic acid comprising a therapeutically effective amount of the compound of claim 4, combined with a pharmaceutically acceptable carrier.
Claim 11
Dependent Claim 33 words
A method of treating a living animal for a non-malignant skin disorder susceptible to treatment by retinoic acid comprising administering a therapeutically effective amount of the compound of claim 1 to the animal.
Claim 12
Dependent Claim 11 words
The method of claim 9 wherein the animal is a human.
Claim 13
Dependent Claim 33 words
A method of treating a living animal for a non-malignant skin disorder susceptible to treatment by retinoic acid comprising administering a therapeutically effective amount of the compound of claim 2 to the animal.
Claim 14
Dependent Claim 11 words
The method of claim 11 where the animal is a human.
Claim 15
Dependent Claim 33 words
A method of treating a living animal for a non-malignant skin disorder susceptible to treatment by retinoic acid comprising administering a therapeutically effective amount of the compound of claim 3 to the animal.
Claim 16
Dependent Claim 11 words
The method of claim 13 wherein the animal is a human.
Claim 17
Dependent Claim 33 words
A method of treating a living animal for a non-malignant skin disorder susceptible to treatment by retinoic acid comprising administering a therapeutically effective amount of the compound of claim 4 to the animal.
Claim 18
Dependent Claim 11 words
The method of claim 15 where the animal is a human.
Claim 19
Dependent Claim 22 words
The therapeutic composition of claim 5 wherein the disorder is icthyoses, a follicular disorder, acne, psoriasis, eczema, atopic dermatitis, or nonspecific dermatitis.
Claim 20
Dependent Claim 21 words
The method of claim 9 wherein the disorder is icthyoses, a follicular disorder, acne, psoriasis, eczema, atopic dermatitis, or nonspecific dermatitis.

References Cited (Backward Citations)

DE2440525A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-07-01 1988-12-31 1989-07-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-07-01 1992-12-31 1993-07-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-07-01 1996-12-31 1997-07-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag